nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0735	0.15	CbGbCtD
Boceprevir—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0631	0.129	CbGbCtD
Boceprevir—ABCB1—Betamethasone—ankylosing spondylitis	0.041	0.084	CbGbCtD
Boceprevir—ABCB1—Prednisolone—ankylosing spondylitis	0.0405	0.0829	CbGbCtD
Boceprevir—ABCB1—Prednisone—ankylosing spondylitis	0.0382	0.0783	CbGbCtD
Boceprevir—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0378	0.0774	CbGbCtD
Boceprevir—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0367	0.0751	CbGbCtD
Boceprevir—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0286	0.0587	CbGbCtD
Boceprevir—CTSK—skeletal joint—ankylosing spondylitis	0.0264	0.37	CbGeAlD
Boceprevir—CYP3A4—Betamethasone—ankylosing spondylitis	0.0246	0.0503	CbGbCtD
Boceprevir—CYP3A4—Prednisolone—ankylosing spondylitis	0.0243	0.0496	CbGbCtD
Boceprevir—ABCB1—Dexamethasone—ankylosing spondylitis	0.0239	0.0489	CbGbCtD
Boceprevir—CYP3A4—Prednisone—ankylosing spondylitis	0.0229	0.0469	CbGbCtD
Boceprevir—ABCB1—Methotrexate—ankylosing spondylitis	0.0192	0.0393	CbGbCtD
Boceprevir—CTSK—cartilage tissue—ankylosing spondylitis	0.0178	0.248	CbGeAlD
Boceprevir—CTSS—synovial membrane of synovial joint—ankylosing spondylitis	0.0176	0.246	CbGeAlD
Boceprevir—CTSL—Endosomal/Vacuolar pathway—HLA-C—ankylosing spondylitis	0.0173	0.0688	CbGpPWpGaD
Boceprevir—CTSV—Endosomal/Vacuolar pathway—HLA-C—ankylosing spondylitis	0.0173	0.0688	CbGpPWpGaD
Boceprevir—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0143	0.0293	CbGbCtD
Boceprevir—CTSS—Endosomal/Vacuolar pathway—HLA-C—ankylosing spondylitis	0.0118	0.0469	CbGpPWpGaD
Boceprevir—CTSV—Endosomal/Vacuolar pathway—HLA-B—ankylosing spondylitis	0.0102	0.0407	CbGpPWpGaD
Boceprevir—CTSL—Endosomal/Vacuolar pathway—HLA-B—ankylosing spondylitis	0.0102	0.0407	CbGpPWpGaD
Boceprevir—CTSV—Endosomal/Vacuolar pathway—HLA-A—ankylosing spondylitis	0.00949	0.0377	CbGpPWpGaD
Boceprevir—CTSL—Endosomal/Vacuolar pathway—HLA-A—ankylosing spondylitis	0.00949	0.0377	CbGpPWpGaD
Boceprevir—CTSS—Endosomal/Vacuolar pathway—HLA-B—ankylosing spondylitis	0.00699	0.0278	CbGpPWpGaD
Boceprevir—CTSS—Endosomal/Vacuolar pathway—HLA-A—ankylosing spondylitis	0.00648	0.0257	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.00533	0.0212	CbGpPWpGaD
Boceprevir—CTSV—Activation of Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.00488	0.0194	CbGpPWpGaD
Boceprevir—CMA1—Activation of Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.00453	0.018	CbGpPWpGaD
Boceprevir—CTSL—Collagen degradation—MMP3—ankylosing spondylitis	0.00425	0.0169	CbGpPWpGaD
Boceprevir—CTSK—Activation of Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.00404	0.016	CbGpPWpGaD
Boceprevir—CTSL—tendon—ankylosing spondylitis	0.00403	0.0564	CbGeAlD
Boceprevir—CTSL—Antigen processing-Cross presentation—HLA-C—ankylosing spondylitis	0.00354	0.0141	CbGpPWpGaD
Boceprevir—CTSV—Antigen processing-Cross presentation—HLA-C—ankylosing spondylitis	0.00354	0.0141	CbGpPWpGaD
Boceprevir—CTSK—Collagen degradation—MMP3—ankylosing spondylitis	0.00352	0.014	CbGpPWpGaD
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—MMP3—ankylosing spondylitis	0.00331	0.0131	CbGpPWpGaD
Boceprevir—CTSL—Assembly of collagen fibrils and other multimeric structures—MMP3—ankylosing spondylitis	0.00331	0.0131	CbGpPWpGaD
Boceprevir—CTSK—tendon—ankylosing spondylitis	0.00303	0.0425	CbGeAlD
Boceprevir—CTSS—tendon—ankylosing spondylitis	0.00266	0.0372	CbGeAlD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—ERAP1—ankylosing spondylitis	0.00246	0.00978	CbGpPWpGaD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—ERAP1—ankylosing spondylitis	0.00246	0.00978	CbGpPWpGaD
Boceprevir—CTSS—Antigen processing-Cross presentation—HLA-C—ankylosing spondylitis	0.00242	0.0096	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP3—ankylosing spondylitis	0.00226	0.00896	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—MMP3—ankylosing spondylitis	0.00225	0.00894	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—MMP3—ankylosing spondylitis	0.00225	0.00894	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP3—ankylosing spondylitis	0.00215	0.00854	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP3—ankylosing spondylitis	0.00215	0.00854	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00212	0.00843	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00212	0.00843	CbGpPWpGaD
Boceprevir—CTSL—Antigen processing-Cross presentation—HLA-B—ankylosing spondylitis	0.0021	0.00832	CbGpPWpGaD
Boceprevir—CTSV—Antigen processing-Cross presentation—HLA-B—ankylosing spondylitis	0.0021	0.00832	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP3—ankylosing spondylitis	0.002	0.00794	CbGpPWpGaD
Boceprevir—CTSL—Antigen processing-Cross presentation—HLA-A—ankylosing spondylitis	0.00194	0.00771	CbGpPWpGaD
Boceprevir—CTSV—Antigen processing-Cross presentation—HLA-A—ankylosing spondylitis	0.00194	0.00771	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—TLR4—ankylosing spondylitis	0.00193	0.00767	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP3—ankylosing spondylitis	0.00178	0.00708	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00176	0.00698	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—ERAP1—ankylosing spondylitis	0.00168	0.00667	CbGpPWpGaD
Boceprevir—CTSS—Collagen formation—MMP3—ankylosing spondylitis	0.00154	0.0061	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP3—ankylosing spondylitis	0.00147	0.00583	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00145	0.00575	CbGpPWpGaD
Boceprevir—CTSS—Antigen processing-Cross presentation—HLA-B—ankylosing spondylitis	0.00143	0.00567	CbGpPWpGaD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—HLA-C—ankylosing spondylitis	0.00141	0.00562	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—HLA-C—ankylosing spondylitis	0.00141	0.00562	CbGpPWpGaD
Boceprevir—CTSS—Antigen processing-Cross presentation—HLA-A—ankylosing spondylitis	0.00132	0.00526	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KIR3DL1—ankylosing spondylitis	0.00129	0.00511	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KIR3DL1—ankylosing spondylitis	0.00129	0.00511	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00122	0.00484	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00122	0.00484	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CARD9—ankylosing spondylitis	0.00116	0.00461	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CARD9—ankylosing spondylitis	0.00116	0.00461	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.00113	0.00448	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.00113	0.00448	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KIR3DL1—ankylosing spondylitis	0.00107	0.00423	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00101	0.00401	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—HLA-C—ankylosing spondylitis	0.000966	0.00383	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CARD9—ankylosing spondylitis	0.000962	0.00382	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000935	0.00371	CbGpPWpGaD
Boceprevir—CTSL—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000928	0.114	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000914	0.113	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000914	0.113	CbGdCrCtD
Boceprevir—CTSL—Extracellular matrix organization—MMP3—ankylosing spondylitis	0.000901	0.00358	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP3—ankylosing spondylitis	0.000901	0.00358	CbGpPWpGaD
Boceprevir—CTSL—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000893	0.11	CbGdCrCtD
Boceprevir—CTSS—Immune System—KIR3DL1—ankylosing spondylitis	0.000879	0.00349	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP3—ankylosing spondylitis	0.000838	0.00333	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—HLA-B—ankylosing spondylitis	0.000837	0.00332	CbGpPWpGaD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—HLA-B—ankylosing spondylitis	0.000837	0.00332	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000832	0.0033	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000802	0.00318	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CARD9—ankylosing spondylitis	0.000793	0.00315	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1R2—ankylosing spondylitis	0.00078	0.0031	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1R2—ankylosing spondylitis	0.00078	0.0031	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—HLA-A—ankylosing spondylitis	0.000775	0.00308	CbGpPWpGaD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—HLA-A—ankylosing spondylitis	0.000775	0.00308	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.00077	0.00306	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP3—ankylosing spondylitis	0.000747	0.00296	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ERAP1—ankylosing spondylitis	0.00074	0.00294	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ERAP1—ankylosing spondylitis	0.00074	0.00294	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—HLA-C—ankylosing spondylitis	0.000729	0.00289	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HLA-C—ankylosing spondylitis	0.000729	0.00289	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.0007	0.00278	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.0007	0.00278	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CARD9—ankylosing spondylitis	0.000676	0.00268	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CARD9—ankylosing spondylitis	0.000676	0.00268	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1R2—ankylosing spondylitis	0.000646	0.00257	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP3—ankylosing spondylitis	0.000615	0.00244	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ERAP1—ankylosing spondylitis	0.000613	0.00243	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—HLA-C—ankylosing spondylitis	0.000604	0.0024	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00058	0.0023	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—HLA-B—ankylosing spondylitis	0.000571	0.00227	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CARD9—ankylosing spondylitis	0.000561	0.00222	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000534	0.00212	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000534	0.00212	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1R2—ankylosing spondylitis	0.000532	0.00211	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—HLA-A—ankylosing spondylitis	0.000529	0.0021	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ERAP1—ankylosing spondylitis	0.000505	0.002	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HLA-C—ankylosing spondylitis	0.000498	0.00198	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000478	0.0019	CbGpPWpGaD
Boceprevir—CTSL—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000471	0.058	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000471	0.058	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Betamethasone—ankylosing spondylitis	0.000463	0.057	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Dexamethasone—ankylosing spondylitis	0.000463	0.057	CbGdCrCtD
Boceprevir—CTSS—Immune System—CARD9—ankylosing spondylitis	0.000462	0.00183	CbGpPWpGaD
Boceprevir—CTSL—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.000453	0.0557	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Triamcinolone—ankylosing spondylitis	0.000453	0.0557	CbGdCrCtD
Boceprevir—CTSK—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000443	0.00176	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000435	0.00173	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000435	0.00173	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HLA-B—ankylosing spondylitis	0.000431	0.00171	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—HLA-B—ankylosing spondylitis	0.000431	0.00171	CbGpPWpGaD
Boceprevir—CTSL—Dexamethasone—Prednisone—ankylosing spondylitis	0.000429	0.0529	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Prednisone—ankylosing spondylitis	0.000429	0.0529	CbGdCrCtD
Boceprevir—CTSV—Immune System—HLA-C—ankylosing spondylitis	0.000425	0.00169	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-C—ankylosing spondylitis	0.000425	0.00169	CbGpPWpGaD
Boceprevir—CTSL—Betamethasone—Prednisolone—ankylosing spondylitis	0.000419	0.0516	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Prednisolone—ankylosing spondylitis	0.000419	0.0516	CbGdCrCtD
Boceprevir—CTSV—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000414	0.00164	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000414	0.00164	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000403	0.0016	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000384	0.00152	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000384	0.00152	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CRP—ankylosing spondylitis	0.000381	0.00151	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CRP—ankylosing spondylitis	0.000381	0.00151	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1RN—ankylosing spondylitis	0.000369	0.00146	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1RN—ankylosing spondylitis	0.000369	0.00146	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000368	0.00146	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TLR4—ankylosing spondylitis	0.000365	0.00145	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TLR4—ankylosing spondylitis	0.000365	0.00145	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000364	0.00145	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000361	0.00143	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—HLA-B—ankylosing spondylitis	0.000357	0.00142	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-C—ankylosing spondylitis	0.000352	0.0014	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000343	0.00136	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000342	0.00136	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD79A—ankylosing spondylitis	0.000324	0.00129	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD79A—ankylosing spondylitis	0.000324	0.00129	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000318	0.00126	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CRP—ankylosing spondylitis	0.000316	0.00125	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1RN—ankylosing spondylitis	0.000306	0.00121	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TLR4—ankylosing spondylitis	0.000303	0.0012	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000297	0.00118	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HLA-B—ankylosing spondylitis	0.000294	0.00117	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-C—ankylosing spondylitis	0.00029	0.00115	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000283	0.00112	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD79A—ankylosing spondylitis	0.000268	0.00107	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1A—ankylosing spondylitis	0.000266	0.00105	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1A—ankylosing spondylitis	0.000266	0.00105	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD40LG—ankylosing spondylitis	0.000264	0.00105	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD40LG—ankylosing spondylitis	0.000264	0.00105	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000262	0.00104	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CRP—ankylosing spondylitis	0.00026	0.00103	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1RN—ankylosing spondylitis	0.000252	0.000999	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.000252	0.000999	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-B—ankylosing spondylitis	0.000251	0.000997	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-B—ankylosing spondylitis	0.000251	0.000997	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.00025	0.000993	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.00025	0.000993	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TLR4—ankylosing spondylitis	0.000249	0.00099	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000239	0.000949	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000238	0.000945	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000237	0.000941	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-A—ankylosing spondylitis	0.000233	0.000924	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-A—ankylosing spondylitis	0.000233	0.000924	CbGpPWpGaD
Boceprevir—Angiopathy—Prednisone—ankylosing spondylitis	0.000231	0.00128	CcSEcCtD
Boceprevir—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000231	0.00128	CcSEcCtD
Boceprevir—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00023	0.00128	CcSEcCtD
Boceprevir—Immune system disorder—Prednisone—ankylosing spondylitis	0.00023	0.00128	CcSEcCtD
Boceprevir—Malaise—Betamethasone—ankylosing spondylitis	0.00023	0.00128	CcSEcCtD
Boceprevir—Malaise—Dexamethasone—ankylosing spondylitis	0.00023	0.00128	CcSEcCtD
Boceprevir—Vertigo—Betamethasone—ankylosing spondylitis	0.000229	0.00127	CcSEcCtD
Boceprevir—Vertigo—Dexamethasone—ankylosing spondylitis	0.000229	0.00127	CcSEcCtD
Boceprevir—Syncope—Dexamethasone—ankylosing spondylitis	0.000228	0.00127	CcSEcCtD
Boceprevir—Syncope—Betamethasone—ankylosing spondylitis	0.000228	0.00127	CcSEcCtD
Boceprevir—Arrhythmia—Prednisone—ankylosing spondylitis	0.000228	0.00126	CcSEcCtD
Boceprevir—Infection—Triamcinolone—ankylosing spondylitis	0.000228	0.00126	CcSEcCtD
Boceprevir—Infection—Methylprednisolone—ankylosing spondylitis	0.000227	0.00126	CcSEcCtD
Boceprevir—Shock—Triamcinolone—ankylosing spondylitis	0.000225	0.00125	CcSEcCtD
Boceprevir—Insomnia—Prednisolone—ankylosing spondylitis	0.000225	0.00125	CcSEcCtD
Boceprevir—Alopecia—Prednisone—ankylosing spondylitis	0.000225	0.00125	CcSEcCtD
Boceprevir—Shock—Methylprednisolone—ankylosing spondylitis	0.000225	0.00125	CcSEcCtD
Boceprevir—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000224	0.00125	CcSEcCtD
Boceprevir—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000224	0.00125	CcSEcCtD
Boceprevir—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000224	0.00124	CcSEcCtD
Boceprevir—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000224	0.00124	CcSEcCtD
Boceprevir—Epistaxis—Methotrexate—ankylosing spondylitis	0.000224	0.00124	CcSEcCtD
Boceprevir—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000224	0.00124	CcSEcCtD
Boceprevir—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000224	0.00124	CcSEcCtD
Boceprevir—Mental disorder—Prednisone—ankylosing spondylitis	0.000223	0.00124	CcSEcCtD
Boceprevir—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000223	0.00124	CcSEcCtD
Boceprevir—CTSV—Immune System—CRP—ankylosing spondylitis	0.000222	0.000881	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CRP—ankylosing spondylitis	0.000222	0.000881	CbGpPWpGaD
Boceprevir—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000222	0.00123	CcSEcCtD
Boceprevir—Erythema—Prednisone—ankylosing spondylitis	0.000222	0.00123	CcSEcCtD
Boceprevir—Malnutrition—Prednisone—ankylosing spondylitis	0.000222	0.00123	CcSEcCtD
Boceprevir—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000221	0.00123	CcSEcCtD
Boceprevir—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000221	0.00123	CcSEcCtD
Boceprevir—CTSS—Immune System—CD79A—ankylosing spondylitis	0.000221	0.000877	CbGpPWpGaD
Boceprevir—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000221	0.00123	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000221	0.000875	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1A—ankylosing spondylitis	0.00022	0.000874	CbGpPWpGaD
Boceprevir—Hypertension—Dexamethasone—ankylosing spondylitis	0.00022	0.00122	CcSEcCtD
Boceprevir—Hypertension—Betamethasone—ankylosing spondylitis	0.00022	0.00122	CcSEcCtD
Boceprevir—CTSK—Immune System—CD40LG—ankylosing spondylitis	0.000219	0.000869	CbGpPWpGaD
Boceprevir—Myalgia—Dexamethasone—ankylosing spondylitis	0.000217	0.0012	CcSEcCtD
Boceprevir—Myalgia—Betamethasone—ankylosing spondylitis	0.000217	0.0012	CcSEcCtD
Boceprevir—Anxiety—Dexamethasone—ankylosing spondylitis	0.000216	0.0012	CcSEcCtD
Boceprevir—Anxiety—Betamethasone—ankylosing spondylitis	0.000216	0.0012	CcSEcCtD
Boceprevir—Discomfort—Betamethasone—ankylosing spondylitis	0.000214	0.00119	CcSEcCtD
Boceprevir—Discomfort—Dexamethasone—ankylosing spondylitis	0.000214	0.00119	CcSEcCtD
Boceprevir—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000214	0.00119	CcSEcCtD
Boceprevir—Pain—Prednisolone—ankylosing spondylitis	0.000213	0.00118	CcSEcCtD
Boceprevir—CTSV—Immune System—TLR4—ankylosing spondylitis	0.000213	0.000845	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TLR4—ankylosing spondylitis	0.000213	0.000845	CbGpPWpGaD
Boceprevir—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000211	0.00117	CcSEcCtD
Boceprevir—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00021	0.00117	CcSEcCtD
Boceprevir—Vision blurred—Prednisone—ankylosing spondylitis	0.000209	0.00116	CcSEcCtD
Boceprevir—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000209	0.00116	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000209	0.00116	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000208	0.00116	CcSEcCtD
Boceprevir—CTSK—Immune System—HLA-B—ankylosing spondylitis	0.000208	0.000826	CbGpPWpGaD
Boceprevir—Insomnia—Triamcinolone—ankylosing spondylitis	0.000207	0.00115	CcSEcCtD
Boceprevir—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000207	0.00115	CcSEcCtD
Boceprevir—Infection—Betamethasone—ankylosing spondylitis	0.000207	0.00115	CcSEcCtD
Boceprevir—Infection—Dexamethasone—ankylosing spondylitis	0.000207	0.00115	CcSEcCtD
Boceprevir—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000206	0.00114	CcSEcCtD
Boceprevir—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000206	0.00114	CcSEcCtD
Boceprevir—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000205	0.00114	CcSEcCtD
Boceprevir—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000205	0.00114	CcSEcCtD
Boceprevir—Visual impairment—Methotrexate—ankylosing spondylitis	0.000205	0.00114	CcSEcCtD
Boceprevir—Anaemia—Prednisone—ankylosing spondylitis	0.000205	0.00114	CcSEcCtD
Boceprevir—Shock—Betamethasone—ankylosing spondylitis	0.000205	0.00114	CcSEcCtD
Boceprevir—Shock—Dexamethasone—ankylosing spondylitis	0.000205	0.00114	CcSEcCtD
Boceprevir—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000204	0.00113	CcSEcCtD
Boceprevir—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000204	0.00113	CcSEcCtD
Boceprevir—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000204	0.00113	CcSEcCtD
Boceprevir—Agitation—Prednisone—ankylosing spondylitis	0.000204	0.00113	CcSEcCtD
Boceprevir—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000204	0.00113	CcSEcCtD
Boceprevir—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000204	0.00113	CcSEcCtD
Boceprevir—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000203	0.00113	CcSEcCtD
Boceprevir—Tachycardia—Betamethasone—ankylosing spondylitis	0.000203	0.00113	CcSEcCtD
Boceprevir—Angioedema—Prednisone—ankylosing spondylitis	0.000203	0.00113	CcSEcCtD
Boceprevir—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000202	0.00112	CcSEcCtD
Boceprevir—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000201	0.00112	CcSEcCtD
Boceprevir—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000201	0.00112	CcSEcCtD
Boceprevir—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000201	0.00112	CcSEcCtD
Boceprevir—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000201	0.00112	CcSEcCtD
Boceprevir—Malaise—Prednisone—ankylosing spondylitis	0.0002	0.00111	CcSEcCtD
Boceprevir—Vertigo—Prednisone—ankylosing spondylitis	0.000199	0.00111	CcSEcCtD
Boceprevir—Eye disorder—Methotrexate—ankylosing spondylitis	0.000199	0.00111	CcSEcCtD
Boceprevir—Syncope—Prednisone—ankylosing spondylitis	0.000199	0.00111	CcSEcCtD
Boceprevir—Tinnitus—Methotrexate—ankylosing spondylitis	0.000199	0.0011	CcSEcCtD
Boceprevir—Urticaria—Prednisolone—ankylosing spondylitis	0.000198	0.0011	CcSEcCtD
Boceprevir—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000198	0.0011	CcSEcCtD
Boceprevir—Fatigue—Triamcinolone—ankylosing spondylitis	0.000198	0.0011	CcSEcCtD
Boceprevir—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000197	0.00109	CcSEcCtD
Boceprevir—Pain—Triamcinolone—ankylosing spondylitis	0.000196	0.00109	CcSEcCtD
Boceprevir—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000195	0.00108	CcSEcCtD
Boceprevir—Hypotension—Betamethasone—ankylosing spondylitis	0.000194	0.00108	CcSEcCtD
Boceprevir—Hypotension—Dexamethasone—ankylosing spondylitis	0.000194	0.00108	CcSEcCtD
Boceprevir—Angiopathy—Methotrexate—ankylosing spondylitis	0.000193	0.00107	CcSEcCtD
Boceprevir—CTSK—Immune System—HLA-A—ankylosing spondylitis	0.000193	0.000765	CbGpPWpGaD
Boceprevir—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000192	0.00107	CcSEcCtD
Boceprevir—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000192	0.00107	CcSEcCtD
Boceprevir—Hypertension—Prednisone—ankylosing spondylitis	0.000192	0.00106	CcSEcCtD
Boceprevir—Chills—Methotrexate—ankylosing spondylitis	0.000191	0.00106	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000189	0.00105	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000189	0.00105	CcSEcCtD
Boceprevir—Myalgia—Prednisone—ankylosing spondylitis	0.000189	0.00105	CcSEcCtD
Boceprevir—Arthralgia—Prednisone—ankylosing spondylitis	0.000189	0.00105	CcSEcCtD
Boceprevir—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000189	0.00105	CcSEcCtD
Boceprevir—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000188	0.00105	CcSEcCtD
Boceprevir—Anxiety—Prednisone—ankylosing spondylitis	0.000188	0.00105	CcSEcCtD
Boceprevir—Alopecia—Methotrexate—ankylosing spondylitis	0.000188	0.00105	CcSEcCtD
Boceprevir—Insomnia—Betamethasone—ankylosing spondylitis	0.000188	0.00104	CcSEcCtD
Boceprevir—Insomnia—Dexamethasone—ankylosing spondylitis	0.000188	0.00104	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000188	0.00104	CcSEcCtD
Boceprevir—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000187	0.00104	CcSEcCtD
Boceprevir—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000187	0.00104	CcSEcCtD
Boceprevir—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000187	0.00104	CcSEcCtD
Boceprevir—Discomfort—Prednisone—ankylosing spondylitis	0.000187	0.00104	CcSEcCtD
Boceprevir—Mental disorder—Methotrexate—ankylosing spondylitis	0.000187	0.00104	CcSEcCtD
Boceprevir—Malnutrition—Methotrexate—ankylosing spondylitis	0.000185	0.00103	CcSEcCtD
Boceprevir—Erythema—Methotrexate—ankylosing spondylitis	0.000185	0.00103	CcSEcCtD
Boceprevir—CTSK—Immune System—CRP—ankylosing spondylitis	0.000184	0.00073	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000184	0.00102	CcSEcCtD
Boceprevir—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000183	0.00102	CcSEcCtD
Boceprevir—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000183	0.00102	CcSEcCtD
Boceprevir—Urticaria—Triamcinolone—ankylosing spondylitis	0.000182	0.00101	CcSEcCtD
Boceprevir—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000182	0.00101	CcSEcCtD
Boceprevir—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000182	0.00101	CcSEcCtD
Boceprevir—CTSS—Immune System—IL1A—ankylosing spondylitis	0.000181	0.000719	CbGpPWpGaD
Boceprevir—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000181	0.00101	CcSEcCtD
Boceprevir—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000181	0.001	CcSEcCtD
Boceprevir—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000181	0.001	CcSEcCtD
Boceprevir—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000181	0.001	CcSEcCtD
Boceprevir—CTSS—Immune System—CD40LG—ankylosing spondylitis	0.00018	0.000715	CbGpPWpGaD
Boceprevir—Infection—Prednisone—ankylosing spondylitis	0.00018	0.000999	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000179	0.000997	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000179	0.000997	CcSEcCtD
Boceprevir—Back pain—Methotrexate—ankylosing spondylitis	0.000179	0.000996	CcSEcCtD
Boceprevir—Fatigue—Betamethasone—ankylosing spondylitis	0.000179	0.000996	CcSEcCtD
Boceprevir—Fatigue—Dexamethasone—ankylosing spondylitis	0.000179	0.000996	CcSEcCtD
Boceprevir—Shock—Prednisone—ankylosing spondylitis	0.000178	0.000989	CcSEcCtD
Boceprevir—Pain—Dexamethasone—ankylosing spondylitis	0.000178	0.000988	CcSEcCtD
Boceprevir—Pain—Betamethasone—ankylosing spondylitis	0.000178	0.000988	CcSEcCtD
Boceprevir—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000178	0.000986	CcSEcCtD
Boceprevir—Tachycardia—Prednisone—ankylosing spondylitis	0.000177	0.000982	CcSEcCtD
Boceprevir—CTSK—Immune System—TLR4—ankylosing spondylitis	0.000176	0.0007	CbGpPWpGaD
Boceprevir—Skin disorder—Prednisone—ankylosing spondylitis	0.000176	0.000977	CcSEcCtD
Boceprevir—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000175	0.000972	CcSEcCtD
Boceprevir—Vision blurred—Methotrexate—ankylosing spondylitis	0.000175	0.000971	CcSEcCtD
Boceprevir—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000172	0.000956	CcSEcCtD
Boceprevir—CTSS—Immune System—HLA-B—ankylosing spondylitis	0.000171	0.00068	CbGpPWpGaD
Boceprevir—Anaemia—Methotrexate—ankylosing spondylitis	0.000171	0.000952	CcSEcCtD
Boceprevir—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000171	0.000952	CcSEcCtD
Boceprevir—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000171	0.000952	CcSEcCtD
Boceprevir—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00017	0.000944	CcSEcCtD
Boceprevir—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00017	0.000944	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000169	0.00067	CbGpPWpGaD
Boceprevir—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000169	0.000938	CcSEcCtD
Boceprevir—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000168	0.000936	CcSEcCtD
Boceprevir—Malaise—Methotrexate—ankylosing spondylitis	0.000167	0.000929	CcSEcCtD
Boceprevir—Vertigo—Methotrexate—ankylosing spondylitis	0.000167	0.000925	CcSEcCtD
Boceprevir—Leukopenia—Methotrexate—ankylosing spondylitis	0.000166	0.000922	CcSEcCtD
Boceprevir—Urticaria—Betamethasone—ankylosing spondylitis	0.000165	0.000917	CcSEcCtD
Boceprevir—Urticaria—Dexamethasone—ankylosing spondylitis	0.000165	0.000917	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000165	0.000916	CcSEcCtD
Boceprevir—Dizziness—Prednisolone—ankylosing spondylitis	0.000165	0.000915	CcSEcCtD
Boceprevir—Asthenia—Triamcinolone—ankylosing spondylitis	0.000164	0.000913	CcSEcCtD
Boceprevir—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000164	0.000913	CcSEcCtD
Boceprevir—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000164	0.000913	CcSEcCtD
Boceprevir—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000164	0.000913	CcSEcCtD
Boceprevir—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000164	0.000913	CcSEcCtD
Boceprevir—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000164	0.000911	CcSEcCtD
Boceprevir—Insomnia—Prednisone—ankylosing spondylitis	0.000164	0.00091	CcSEcCtD
Boceprevir—Paraesthesia—Prednisone—ankylosing spondylitis	0.000163	0.000903	CcSEcCtD
Boceprevir—Pruritus—Triamcinolone—ankylosing spondylitis	0.000162	0.0009	CcSEcCtD
Boceprevir—Cough—Methotrexate—ankylosing spondylitis	0.000162	0.000899	CcSEcCtD
Boceprevir—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000162	0.000898	CcSEcCtD
Boceprevir—Dyspepsia—Prednisone—ankylosing spondylitis	0.000159	0.000885	CcSEcCtD
Boceprevir—CTSS—Immune System—HLA-A—ankylosing spondylitis	0.000159	0.00063	CbGpPWpGaD
Boceprevir—Chest pain—Methotrexate—ankylosing spondylitis	0.000158	0.000877	CcSEcCtD
Boceprevir—Myalgia—Methotrexate—ankylosing spondylitis	0.000158	0.000877	CcSEcCtD
Boceprevir—Arthralgia—Methotrexate—ankylosing spondylitis	0.000158	0.000877	CcSEcCtD
Boceprevir—Decreased appetite—Prednisone—ankylosing spondylitis	0.000157	0.000874	CcSEcCtD
Boceprevir—Rash—Prednisolone—ankylosing spondylitis	0.000157	0.000873	CcSEcCtD
Boceprevir—Dermatitis—Prednisolone—ankylosing spondylitis	0.000157	0.000872	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000157	0.000871	CcSEcCtD
Boceprevir—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000156	0.000869	CcSEcCtD
Boceprevir—Fatigue—Prednisone—ankylosing spondylitis	0.000156	0.000867	CcSEcCtD
Boceprevir—Headache—Prednisolone—ankylosing spondylitis	0.000156	0.000867	CcSEcCtD
Boceprevir—Discomfort—Methotrexate—ankylosing spondylitis	0.000156	0.000866	CcSEcCtD
Boceprevir—Constipation—Prednisone—ankylosing spondylitis	0.000155	0.00086	CcSEcCtD
Boceprevir—Confusional state—Methotrexate—ankylosing spondylitis	0.000153	0.000847	CcSEcCtD
Boceprevir—CTSS—Immune System—CRP—ankylosing spondylitis	0.000152	0.000601	CbGpPWpGaD
Boceprevir—Dizziness—Triamcinolone—ankylosing spondylitis	0.000151	0.000842	CcSEcCtD
Boceprevir—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000151	0.00084	CcSEcCtD
Boceprevir—Infection—Methotrexate—ankylosing spondylitis	0.00015	0.000835	CcSEcCtD
Boceprevir—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000149	0.000829	CcSEcCtD
Boceprevir—Asthenia—Dexamethasone—ankylosing spondylitis	0.000149	0.000829	CcSEcCtD
Boceprevir—Asthenia—Betamethasone—ankylosing spondylitis	0.000149	0.000829	CcSEcCtD
Boceprevir—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000148	0.000824	CcSEcCtD
Boceprevir—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000148	0.000823	CcSEcCtD
Boceprevir—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000148	0.000822	CcSEcCtD
Boceprevir—Nausea—Prednisolone—ankylosing spondylitis	0.000148	0.000822	CcSEcCtD
Boceprevir—Pruritus—Dexamethasone—ankylosing spondylitis	0.000147	0.000817	CcSEcCtD
Boceprevir—Pruritus—Betamethasone—ankylosing spondylitis	0.000147	0.000817	CcSEcCtD
Boceprevir—Skin disorder—Methotrexate—ankylosing spondylitis	0.000147	0.000816	CcSEcCtD
Boceprevir—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000146	0.000813	CcSEcCtD
Boceprevir—Vomiting—Triamcinolone—ankylosing spondylitis	0.000146	0.000809	CcSEcCtD
Boceprevir—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000145	0.000807	CcSEcCtD
Boceprevir—CTSS—Immune System—TLR4—ankylosing spondylitis	0.000145	0.000577	CbGpPWpGaD
Boceprevir—Rash—Triamcinolone—ankylosing spondylitis	0.000144	0.000803	CcSEcCtD
Boceprevir—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000144	0.000802	CcSEcCtD
Boceprevir—Rash—Methylprednisolone—ankylosing spondylitis	0.000144	0.000801	CcSEcCtD
Boceprevir—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000144	0.0008	CcSEcCtD
Boceprevir—Urticaria—Prednisone—ankylosing spondylitis	0.000144	0.000799	CcSEcCtD
Boceprevir—Headache—Triamcinolone—ankylosing spondylitis	0.000144	0.000797	CcSEcCtD
Boceprevir—Headache—Methylprednisolone—ankylosing spondylitis	0.000143	0.000796	CcSEcCtD
Boceprevir—Body temperature increased—Prednisone—ankylosing spondylitis	0.000143	0.000795	CcSEcCtD
Boceprevir—Abdominal pain—Prednisone—ankylosing spondylitis	0.000143	0.000795	CcSEcCtD
Boceprevir—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000142	0.00079	CcSEcCtD
Boceprevir—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000142	0.00079	CcSEcCtD
Boceprevir—Hypotension—Methotrexate—ankylosing spondylitis	0.000141	0.000785	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000138	0.000766	CcSEcCtD
Boceprevir—Dizziness—Dexamethasone—ankylosing spondylitis	0.000137	0.000764	CcSEcCtD
Boceprevir—Dizziness—Betamethasone—ankylosing spondylitis	0.000137	0.000764	CcSEcCtD
Boceprevir—Insomnia—Methotrexate—ankylosing spondylitis	0.000137	0.00076	CcSEcCtD
Boceprevir—Nausea—Triamcinolone—ankylosing spondylitis	0.000136	0.000756	CcSEcCtD
Boceprevir—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000136	0.000755	CcSEcCtD
Boceprevir—Nausea—Methylprednisolone—ankylosing spondylitis	0.000136	0.000754	CcSEcCtD
Boceprevir—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000135	0.000749	CcSEcCtD
Boceprevir—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000133	0.000741	CcSEcCtD
Boceprevir—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000133	0.00074	CcSEcCtD
Boceprevir—Vomiting—Dexamethasone—ankylosing spondylitis	0.000132	0.000734	CcSEcCtD
Boceprevir—Vomiting—Betamethasone—ankylosing spondylitis	0.000132	0.000734	CcSEcCtD
Boceprevir—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000132	0.000731	CcSEcCtD
Boceprevir—Rash—Betamethasone—ankylosing spondylitis	0.000131	0.000728	CcSEcCtD
Boceprevir—Rash—Dexamethasone—ankylosing spondylitis	0.000131	0.000728	CcSEcCtD
Boceprevir—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000131	0.000727	CcSEcCtD
Boceprevir—Dermatitis—Betamethasone—ankylosing spondylitis	0.000131	0.000727	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000131	0.000726	CcSEcCtD
Boceprevir—Fatigue—Methotrexate—ankylosing spondylitis	0.00013	0.000725	CcSEcCtD
Boceprevir—Headache—Betamethasone—ankylosing spondylitis	0.00013	0.000723	CcSEcCtD
Boceprevir—Headache—Dexamethasone—ankylosing spondylitis	0.00013	0.000723	CcSEcCtD
Boceprevir—Asthenia—Prednisone—ankylosing spondylitis	0.00013	0.000722	CcSEcCtD
Boceprevir—Pain—Methotrexate—ankylosing spondylitis	0.000129	0.000719	CcSEcCtD
Boceprevir—Pruritus—Prednisone—ankylosing spondylitis	0.000128	0.000712	CcSEcCtD
Boceprevir—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000125	0.000693	CcSEcCtD
Boceprevir—Diarrhoea—Prednisone—ankylosing spondylitis	0.000124	0.000688	CcSEcCtD
Boceprevir—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000124	0.000687	CcSEcCtD
Boceprevir—Nausea—Betamethasone—ankylosing spondylitis	0.000123	0.000686	CcSEcCtD
Boceprevir—Nausea—Dexamethasone—ankylosing spondylitis	0.000123	0.000686	CcSEcCtD
Boceprevir—Urticaria—Methotrexate—ankylosing spondylitis	0.00012	0.000668	CcSEcCtD
Boceprevir—Dizziness—Prednisone—ankylosing spondylitis	0.00012	0.000665	CcSEcCtD
Boceprevir—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00012	0.000664	CcSEcCtD
Boceprevir—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00012	0.000664	CcSEcCtD
Boceprevir—Vomiting—Prednisone—ankylosing spondylitis	0.000115	0.000639	CcSEcCtD
Boceprevir—Rash—Prednisone—ankylosing spondylitis	0.000114	0.000634	CcSEcCtD
Boceprevir—Dermatitis—Prednisone—ankylosing spondylitis	0.000114	0.000634	CcSEcCtD
Boceprevir—Headache—Prednisone—ankylosing spondylitis	0.000113	0.00063	CcSEcCtD
Boceprevir—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000111	0.000619	CcSEcCtD
Boceprevir—Asthenia—Methotrexate—ankylosing spondylitis	0.000109	0.000603	CcSEcCtD
Boceprevir—Nausea—Prednisone—ankylosing spondylitis	0.000108	0.000597	CcSEcCtD
Boceprevir—Pruritus—Methotrexate—ankylosing spondylitis	0.000107	0.000595	CcSEcCtD
Boceprevir—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000104	0.000575	CcSEcCtD
Boceprevir—Dizziness—Methotrexate—ankylosing spondylitis	0.0001	0.000556	CcSEcCtD
Boceprevir—Vomiting—Methotrexate—ankylosing spondylitis	9.62e-05	0.000534	CcSEcCtD
Boceprevir—Rash—Methotrexate—ankylosing spondylitis	9.54e-05	0.00053	CcSEcCtD
Boceprevir—Dermatitis—Methotrexate—ankylosing spondylitis	9.53e-05	0.000529	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	9.52e-05	0.000378	CbGpPWpGaD
Boceprevir—Headache—Methotrexate—ankylosing spondylitis	9.48e-05	0.000527	CcSEcCtD
Boceprevir—Nausea—Methotrexate—ankylosing spondylitis	8.99e-05	0.000499	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	6.63e-05	0.000263	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	5e-05	0.000199	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	4.7e-05	0.000187	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	3.08e-05	0.000122	CbGpPWpGaD
